
X
FDA hastens development of Novartis’ Kymriah in follicular lymphoma
https://pharmaphorum.com/news/fda-hastens-development-of-novartis-kymriah-in-follicular-lymphoma/
UK biotech will supply key component of Novartis’ newly approved cancer cell therapy